Ethyl Oleate

Ethyl Oleate

SCHEMBL17443164

CCCCCCCC/C=C\CCCCCCCC(=O)OCC.CCCCCCCC/C=C\CCCCCCCCO

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 2/20 0.65
▸ HSD17B10 Q99714 2/20 0.65
▸ ALDH1A1 P00352 1/20 0.65
▸ CYP3A4 P08684 1/20 0.65
▸ TSHR P16473 1/20 0.65
▸ TDP1 Q9NUW8 1/20 0.65
▸ DGKA P23743 1/20 0.62
▸ FAAH O00519 2/20 0.62
▸ MGLL Q99685 1/20 0.61
▸ CNR2 P34972 1/20 0.60
▸ PRKCE Q02156 1/20 0.59
▸ PRKCQ Q04759 1/20 0.59
▸ PRKCD Q05655 1/20 0.59
▸ PRKCA P17252 1/20 0.59
▸ EPHX2 P34913 1/20 0.55
▸ NR1I2 O75469 1/20 0.55
▸ PGR P06401 1/20 0.55
▸ ADORA3 P0DMS8 1/20 0.55
▸ PTGS2 P35354 1/20 0.55
▸ PDE4D Q08499 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18960608 0.95 ALDH1A1 (0.71) ALOX15HSD17B10ALDH1A1CYP3A4TSHR
SCHEMBL28537632 0.95 ALDH1A1 (0.71) ALOX15HSD17B10ALDH1A1CYP3A4TSHR
SCHEMBL7053932 0.95 ALDH1A1 (0.71) ALOX15HSD17B10ALDH1A1CYP3A4TSHR
SCHEMBL18960823 0.95 ALDH1A1 (0.71) ALOX15HSD17B10ALDH1A1CYP3A4TSHR
SCHEMBL18960607 0.95 ALDH1A1 (0.71) ALOX15HSD17B10ALDH1A1CYP3A4TSHR
SCHEMBL28528192 0.95 ALDH1A1 (0.71) ALOX15HSD17B10ALDH1A1CYP3A4TSHR
SCHEMBL18960824 0.95 ALDH1A1 (0.71) ALOX15HSD17B10ALDH1A1CYP3A4TSHR
Ethyl Oleate SCHEMBL6369771 0.93 ALOX15 (0.69) ALOX15HSD17B10ALDH1A1CYP3A4TSHR
Ethyl Oleate SCHEMBL6369777 0.93 ALOX15 (0.69) ALOX15HSD17B10ALDH1A1CYP3A4TSHR
SCHEMBL25490302 0.93 HSD17B10 (0.73) ALOX15HSD17B10ALDH1A1CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3169317-B1 OXYMORPHONE TRANSDERMAL PATCH BUZZZ PHARMACEUTICALS LTD (IE) 2020-04-08 — — EP disclosed
EP-3169318-B1 ABUSE DETERRENT OPIOD/OPIOD-ANTAGONIST TRANSDERMAL PATCH BUZZZ PHARMACEUTICALS LTD (IE) 2020-04-01 — — EP disclosed
US-10238648-B2 Abuse deterrent opioid/opioid-antagonist transdermal patch BUZZZ PHARMACEUTICALS LTD. (IE) 2019-03-26 — — US disclosed
US-10071090-B2 Oxymorphone transdermal patch BUZZZ PHARMACEUTICALS LIMITED (IE) 2018-09-11 — — US disclosed
US-20170209429-A1 ABUSE DETERRENT OPIOD/OPIOD-ANTAGONIST TRANSDERMAL PATCH BUZZZ PHARMACEUTICALS LIMITED (IE) 2017-07-27 — — US disclosed
US-20170202830-A1 OXYMORPHONE TRANSDERMAL PATCH BUZZZ PHARMACEUTICALS LIMITED (IE) 2017-07-20 — — US disclosed
EP-3169317-A1 OXYMORPHONE TRANSDERMAL PATCH Buzzz Pharmaceuticals Limited (IE) 2017-05-24 — — EP disclosed
EP-3169318-A1 ABUSE DETERRENT OPIOD/OPIOD-ANTAGONIST TRANSDERMAL PATCH Buzzz Pharmaceuticals Limited (IE) 2017-05-24 — — EP disclosed
WO-2016009063-A1 OXYMORPHONE TRANSDERMAL PATCH BUZZZ PHARMACEUTICALS LIMITED (IE) 2016-01-21 — — WO disclosed
WO-2016009064-A1 ABUSE DETERRENT OPIOD/OPIOD-ANTAGONIST TRANSDERMAL PATCH BUZZZ PHARMACEUTICALS LIMITED (IE) 2016-01-21 — — WO disclosed
Send feedback